Cargando…
Efficacy and Safety of Rituximab in Hepatitis B Virus–Associated PLA2R-Positive Membranous Nephropathy
Autores principales: | Berchtold, Lena, Zanetta, Gilbert, Dahan, Karine, Mihout, Fabrice, Peltier, Julie, Guerrot, Dominique, Brochériou, Isabelle, Ronco, Pierre, Debiec, Hanna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Elsevier
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5932116/ https://www.ncbi.nlm.nih.gov/pubmed/29725654 http://dx.doi.org/10.1016/j.ekir.2017.09.009 |
Ejemplares similares
-
The Role of PLA2R Antibody in Treatment of Membranous Nephropathy
por: Dahan, Karine, et al.
Publicado: (2017) -
Efficacy of Rituximab in a Patient With Partial Clinical Remission and Persistent Circulating PLA2R-Ab
por: Georges, Elodie, et al.
Publicado: (2019) -
Prognostic value of PLA2R autoimmunity detected by measurement of anti-PLA2R antibodies combined with detection of PLA2R antigen in membranous nephropathy: A single-centre study over 14 years
por: Pourcine, Franck, et al.
Publicado: (2017) -
Analysis and Management of Rituximab Resistance in PLA2R1-Associated Membranous Nephropathy
por: Teisseyre, Maxime, et al.
Publicado: (2021) -
Concurrent PLA2R-Associated Membranous Nephropathy and Antiglomerular Basement Membrane Disease
por: Jagannathan, Geetha, et al.
Publicado: (2022)